Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAGODA: Proactive Graduated Dose Modification Algorithm for FOLFOX Chemotherapy
NCT07283939Recruiting
- Sponsor
- Cancer and Leukemia Group B
- Start
- Feb 2026
- Primary completion
- May 2030
- Countries
- 3
01
Overview
Randomised, open-label trial in gastrointestinal cancer (2 arms), sponsored by Cancer and Leukemia Group B. Primary endpoint: Incidence of unplanned chemotherapy delays. Started Feb 2026; status: recruiting.
02
Conditions
gastrointestinal cancer
Beyond the preview
Go deeper on NCT07283939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07283939.